Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Revenue

Relay Therapeutics had revenue of $10.01M in the twelve months ending September 30, 2024, down -61.22% year-over-year. In the year 2023, Relay Therapeutics had annual revenue of $25.55M with 1,749.82% growth.

• Revenue (ttm): $10.01M
• Revenue Growth: -61.22%
• P/S Ratio: 57.33
• Revenue / Employee: $30,978
• Employees: 323
• Market Cap: 710.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.55M	24.17M	1,749.82%
Dec 31, 2022	1.38M	-1.65M	-54.41%
Dec 31, 2021	3.03M	-79.63M	-96.34%
Dec 31, 2020	82.65M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.